CeMM congratulates the Children's Cancer Research Institute (CCRI) to its new Scientific Director Kaan Boztug
On March 7, the CCRI announced that Kaan Boztug took over his new role as Scientific Director of the Children's Cancer Research Institute.
As physician-scientist and leading expert in primary immunodeficiency and hematological malignancies, Kaan is a perfect choice for the directorship of this renowned research institution in paediatric oncology and we hope that his appointment will further strengthen the links between our organizations. Kaan joined CeMM as Principal Investigator in 2011, and has been pursuing a steep career ever since. Two ERC Grants, several prizes and awards, an impressive publication track record, and successful national and international collaborations prove that Kaan Boztug and his research team embody “precision medicine” at its best.
Dear Kaan, on behalf of your colleagues and friends at CeMM, congratulations to your achievements, and all the best for your future endeavors!
Kaan Boztug studied Medicine in Düsseldorf, Freiburg and London, followed by his graduate training with Iain Campbell at the Scripps Research Institute (La Jolla, USA), and clinical training and postgraduate research with Christoph Klein at Hannover Medical School (Germany). He joined CeMM in 2011 and holds a dual appointment as Associate Professor at the Department of Paediatrics and Adolescent Medicine at the Medical University of Vienna. He is director of the CeRUD Vienna Center for Rare and Undiagnosed Diseases and joint director of the Jeffrey Modell Foundation Center for Immunodeficiencies at the Medical University of Vienna and St. Anna Children’s Hospital. Since 2016, Kaan Boztug is leading the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases. CeMM, the Medical University of Vienna, and the Children´s Cancer Research Institute of St. Anna Children’s Hospital are official partners of LBI-RUD.
Links zum Thema
Artikel teilen
